A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
At 38, William Lindley was a father of three kids and passionate about his job in law enforcement. But, after months of ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
HOUSTON ― A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or ...
Breast cancer can be treated WITHOUT surgery? New study spills the beans on stroke-prevention pacemaker that works on ...
An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback